28087473|t|Salvianolic Acids for Injection (SAFI) suppresses inflammatory responses in activated microglia to attenuate brain damage in focal cerebral ischemia
28087473|a|Inflammatory reactions induced by microglia in the brain play crucial roles in ischemia / reperfusion (I/R) cerebral injuries. Microglia activation has been shown to be closely related to TLR4 / NF-κB signal pathways. Salvianolic acids for injection (SAFI) have been used in clinical practice to treat ischemic stroke with reported neuroprotective effects; however, the underlying mechanisms are still uncertain. First, we studied the effect of SAFI on inflammatory responses in LPS - stimulated BV-2 microglia. Then, to discover whether the beneficial in vitro effects of SAFI lead to in vivo therapeutic effect s, an MCAO (Middle cerebral artery occlusion) rat model was further employed to elucidate the probable mechanism of SAFI in treating ischemic stroke. Rats in the SAFI group were given SAFI (23 or 46mg/kg) before I / R injury. The results showed that SAFI treatment significantly decreased neuroinflammation and the infarction volume compared with the vehicle group. Activation of microglia cells was reduced, and TLR4 / NF-κB signals, which were markedly inhibited by SAFI treatment in ischemic hemisphere, were accompanied by reduced expression and release of cytokines IL-1β and IL-6. This study provides evidence that SAFI effectively protects the brain after cerebral ischemia, which may be caused by attenuating inflammation in microglia.
28087473	0	17	Salvianolic Acids	T109	C3252265
28087473	22	31	Injection	T122	C1272883
28087473	33	37	SAFI	T122	C1272883
28087473	39	49	suppresses	T169	C1260953
28087473	50	72	inflammatory responses	T046	C1155266
28087473	76	85	activated	T052	C1879547
28087473	86	95	microglia	T025	C0206116
28087473	99	108	attenuate	T052	C0599946
28087473	109	121	brain damage	T037	C0270611
28087473	125	148	focal cerebral ischemia	T047	C0917798
28087473	149	171	Inflammatory reactions	T046	C0021368
28087473	183	192	microglia	T025	C0206116
28087473	200	205	brain	T023	C0006104
28087473	219	224	roles	T077	C1705810
28087473	228	236	ischemia	T047	C0007786
28087473	239	274	reperfusion (I/R) cerebral injuries	T037	C3854511
28087473	276	285	Microglia	T025	C0206116
28087473	286	296	activation	T052	C1879547
28087473	337	341	TLR4	T044	C2247725
28087473	344	365	NF-κB signal pathways	T045	C1513838
28087473	367	384	Salvianolic acids	T109	C3252265
28087473	389	398	injection	T122	C1272883
28087473	400	404	SAFI	T122	C1272883
28087473	424	441	clinical practice	T057	C0205897
28087473	445	450	treat	T169	C1522326
28087473	451	466	ischemic stroke	T047	C0948008
28087473	472	480	reported	T058	C0700287
28087473	481	504	neuroprotective effects	T169	C0815279
28087473	530	540	mechanisms	T169	C0441712
28087473	572	579	studied	T062	C2603343
28087473	584	590	effect	T080	C1280500
28087473	594	598	SAFI	T122	C1272883
28087473	602	624	inflammatory responses	T046	C1155266
28087473	628	631	LPS	T109	C0023810
28087473	634	644	stimulated	T070	C1948023
28087473	645	649	BV-2	T007	C4075604
28087473	650	659	microglia	T025	C0206116
28087473	670	678	discover	T052	C1880355
28087473	691	701	beneficial	T081	C0814225
28087473	702	710	in vitro	T062	C0681828
28087473	711	718	effects	T080	C1280500
28087473	722	726	SAFI	T122	C1272883
28087473	735	742	in vivo	T062	C0681829
28087473	743	761	therapeutic effect	T201	C1527144
28087473	768	772	MCAO	T020	C0740391
28087473	774	806	Middle cerebral artery occlusion	T020	C0740391
28087473	808	811	rat	T015	C0034721
28087473	812	817	model	T050	C0012644
28087473	830	838	employed	T033	C0557351
28087473	865	874	mechanism	T169	C0441712
28087473	878	882	SAFI	T122	C1272883
28087473	886	894	treating	T169	C1522326
28087473	895	910	ischemic stroke	T047	C0948008
28087473	912	916	Rats	T015	C0034721
28087473	924	928	SAFI	T122	C1272883
28087473	929	934	group	T078	C0441833
28087473	946	950	SAFI	T122	C1272883
28087473	974	975	I	T047	C0917798
28087473	978	986	R injury	T037	C3854511
28087473	992	999	results	T169	C1274040
28087473	1012	1016	SAFI	T122	C1272883
28087473	1017	1026	treatment	T169	C1522326
28087473	1027	1050	significantly decreased	T081	C4055638
28087473	1051	1068	neuroinflammation	T046	C0021368
28087473	1077	1087	infarction	T046	C0021308
28087473	1088	1094	volume	T081	C0449468
28087473	1113	1120	vehicle	T122	C0042444
28087473	1121	1126	group	T078	C0441833
28087473	1128	1138	Activation	T052	C1879547
28087473	1142	1157	microglia cells	T025	C0206116
28087473	1162	1169	reduced	T080	C0392756
28087473	1175	1179	TLR4	T044	C2247725
28087473	1182	1195	NF-κB signals	T045	C1513838
28087473	1217	1226	inhibited	T080	C0311403
28087473	1230	1234	SAFI	T122	C1272883
28087473	1235	1244	treatment	T169	C1522326
28087473	1248	1256	ischemic	T169	C0475224
28087473	1257	1267	hemisphere	T023	C0228174
28087473	1289	1296	reduced	T080	C0392756
28087473	1297	1307	expression	T045	C1171362
28087473	1312	1319	release	T058	C0680255
28087473	1323	1332	cytokines	T116,T129	C0079189
28087473	1333	1338	IL-1β	T116,T129	C0021753
28087473	1343	1347	IL-6	T116,T129	C0021760
28087473	1354	1359	study	T062	C2603343
28087473	1369	1377	evidence	T078	C3887511
28087473	1383	1387	SAFI	T122	C1272883
28087473	1388	1399	effectively	T080	C1704419
28087473	1413	1418	brain	T023	C0006104
28087473	1425	1442	cerebral ischemia	T047	C0917798
28087473	1467	1478	attenuating	T052	C0599946
28087473	1479	1491	inflammation	T046	C0021368
28087473	1495	1504	microglia	T025	C0206116